News Conference News STS 2022 Modified Surgical MV Repair Stands Up to Replacement Michael O'Riordan February 03, 2022
Presentation THT 2022 Clinical Trials During COVID-19: Innvestigator Perspective Presenter: Scott Solomon February 02, 2022
Presentation THT 2022 Heart Failure Trials in the Modern Era: Where Are We Going? Presenter: Andrew Farb February 02, 2022
News Industry News Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients February 02, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
Presentation THT 2022 Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines Presenter: Milton Packer February 01, 2022
Presentation THT 2022 Omecamtiv Mecarbil - Is It More Effective in Low EFs Presenter: John Teerlink February 01, 2022
Presentation THT 2022 Secubitirl-Valsartan Across the Spectrum of EFs Presenter: Scott Solomon February 01, 2022
Presentation THT 2022 SGLT2 Inhibitors: What the Clinician Should Know Presenter: Stefan Anker February 01, 2022
News Daily News Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse Todd Neale January 21, 2022
News Opinion Fellow Talk A Trainee’s Perspective on the First Genetically Engineered Pig-to-Human Cardiac Xenotransplantation Corbin E. Goerlich, MD January 13, 2022
News Daily News With First-in-Human Porcine Heart Transplant, a New Chapter Begins Yael L. Maxwell January 11, 2022
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients Todd Neale December 14, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021